Skip to main content

Table 2 Clinical characteristics of HIV-infected women (n=2,501)

From: Cervical cancer risk factors among HIV-infected Nigerian women

  n (%) Missing (%)
BMI (kg/m2)   1840 (73.6)
   <18.5 46 (7)  
   18.5–24.9 401 (61)  
   25–29.9 49 (7)  
   ≥30 165 (25)  
Vaginal wall abnormality   0 (0)
   None 2241 (90)  
   Other1 260 (10)  
VIA   0 (0)
   Negative 2344 (94)  
   Positive 155 (6)  
   Invasive cancer 2 (0)  
Last CD4 count (per mm3)   365 (14.6)
   <300 490 (23)  
   300–<450 560 (26)  
   450–<650 592 (28)  
   ≥650 494 (23)  
WHO stage   1118 (44.7)
   Stage 1 1185 (86)  
   Stage 2 104 (7)  
   Stage 3 84 (6)  
   Stage 4 10 (1)  
ART regimen currently on2   1008 (40)
   TDF-containing ART3 778 (52)  
   ZDV-containing ART4 600 (40)  
   d4T-containing ART5 115 (8)  
  1. 1Other includes discharge, lesion, warts, lesion and warts, warts and discharge, and other observations.
  2. 2All women were on ART, the regimen information here is based on those that were verified from clinical records.
  3. 3TDF: Tenofovir.
  4. 4ZDV: Zidovudine.
  5. 5d4T: Stavudine.